相关实验视频

Updated: Jun 13, 2025

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

免疫检查点及其一些抑制剂的蛋白质组调查

Marco Agostini¹, Pietro Traldi¹, Mahmoud Hamdan¹

¹Istituto di Ricerca Pediatrica Città della Speranza, Corso Stati Uniti 4, 35100 Padova, Italy.

International journal of molecular sciences

|September 14, 2024

概括

免疫检查点抑制剂增强抗瘤反应,但面临诸如耐药性和识别反应良好的患者等挑战. 进一步的研究,包括蛋白质组分析,对于提高癌症免疫疗法的有效性至关重要.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物化学生物化学

背景情况:

免疫检查点通过受体-连接体相互作用调节抗瘤免疫反应.
向细胞毒性T淋巴细胞抗原-4,编程细胞死亡-1和编程细胞死亡连接体-1的抑制剂是癌症免疫治疗的关键.
虽然对一些人有效,但检查点抑制剂显示出中度的反应率和获得的耐药性,类似于化疗.

研究的目的:

审查免疫检查点,它们的抑制剂,以及它们在癌症免疫治疗中的作用.
要突出基于质谱的蛋白质组分析在理解这些相互作用的应用.
讨论改善癌症免疫疗法的挑战和未来方向.

主要方法:

审查关于免疫检查点和抑制剂的现有文献.
在免疫疗法研究的背景下,讨论基于质谱的蛋白质组分析.

主要成果:

免疫检查点抑制剂用于约50种癌症类型,单独或与化疗一起使用.
了解耐药机制和识别预测生物标志物对于增强治疗效益至关重要.
蛋白质组分析提供了对检查点相互作用和潜在治疗点的见解.

结论:

克服免疫治疗方面的挑战,包括抵抗性和生物标志物识别,对于更广泛的患者利益至关重要.
对免疫检查点功能和抑制剂开发的持续研究对于推进癌症治疗至关重要.
基于质谱的蛋白质组学可以帮助开发更有效和个性化的癌症免疫疗法.

关键词:

免疫检查点的检查点.免疫系统免疫系统免疫治疗检查点抑制剂/疗法后翻译修改 (PTMs) 是指翻译后的修改.蛋白质组的研究.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins

Published on: January 8, 2018

相关概念视频

Proteomics

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...

Protein-protein Interfaces

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...